Involvement of 5-HT1A receptor mechanisms in the inhibitory effects of methamphetamine on photic responses in the rodent suprachiasmatic nucleus

被引:6
|
作者
Moriya, T
Yamanouchi, S
Fukushima, T
Shimazoe, T
Shibata, S
Watanabe, S
机构
[1] WASEDA UNIV,SCH HUMAN SCI,DEPT PHARMACOL,TOKOROZAWA,SAITAMA 359,JAPAN
[2] KYUSHU UNIV,DEPT PHARMACOL,FAC PHARMACEUT SCI,FUKUOKA 81282,JAPAN
关键词
circadian rhythm; suprachiasmatic nucleus; methamphetamine; NAN-190; 5-HT1A receptor; serotonin;
D O I
10.1016/S0006-8993(96)00860-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We examined the role of serotonin IA (5-HT1A) receptors in the inhibitory effects of methamphetamine (MA) on photic entrainment to the circadian pacemaker in the suprachiasmatic nucleus (SCN) of rodents. MA inhibited optic nerve stimulation-evoked field potential in the SCN, light-induced Fos expression in the SCN and light-induced phase shift of hamster wheel-running rhythm. NAN-190, a 5-HT1A receptor antagonist, eliminated the inhibitory effects of MA. NAN-190 has also been reported to antagonize alpha 1 adrenergic receptors. However, prazosin, which selectively antagonizes alpha(1) adrenergic receptors, did not affect the inhibitory action of RIA on light-induced Fos expression. In addition, parachloroamphetamine, which is known to be a 5-HT releaser, dose-dependently inhibited light-induced phase shift of wheel-running rhythm. These findings suggest that elevation of endogenous 5-HT levels by RIA inhibits the photic entraining responses of the circadian pacemaker in the SCN via 5-HT1A receptor stimulation of the 5-HT released by MA.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 50 条
  • [31] EVIDENCE FOR THE INVOLVEMENT OF THE 5-HT1A RECEPTOR IN THE ANXIOLYTIC ACTION OF INDORENATE AND IPSAPIRONE
    FERNANDEZGUASTI, A
    LOPEZRUBALCAVA, C
    PSYCHOPHARMACOLOGY, 1990, 101 (03) : 354 - 358
  • [32] 5-HT1a Receptor Involvement in Temporal Memory and the Response to Temporal Ambiguity
    Shapiro, Zvi R.
    Cerasiello, Samantha
    Hartshorne, Loryn
    Matell, Matthew S.
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [33] Differential involvement of 5-HT1A receptor in the antinociceptive and antidepressant effect of venlafaxine
    Berrocoso, E
    Rojas-Corrales, O
    Mice, JA
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S360 - S361
  • [34] EVIDENCE FOR 5-HT1A RECEPTOR INVOLVEMENT IN THE CONTROL OF PROLACTIN SECRETION IN MAN
    PALAZIDOU, E
    STEPHENSON, J
    MCGREGOR, A
    BUTLER, J
    COSKERAN, P
    NEUROPSYCHOPHARMACOLOGY, 1993, 9 (02) : S157 - S157
  • [35] EVIDENCE FOR THE INVOLVEMENT OF THE 5-HT1A RECEPTOR IN CCK INDUCED SATIETY IN RATS
    VOIGT, JP
    FINK, H
    MARSDEN, CA
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1995, 351 (03) : 217 - 220
  • [36] Involvement of the 5-HT1A receptor in sex differences of mice in anti-immobility effects of fluvoxamine
    Sugimoto, Yumi
    Furutani, Sachiko
    Taki, Yuko
    Hirano, Kazufumi
    Yamada, Shizuo
    Hotta, Yoshihiro
    Yamada, Jun
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 179P - 179P
  • [37] Antidepressant-like effects of Albizzia julibrissin in mice:: Involvement of the 5-HT1A receptor system
    Kim, Ji-Hyun
    Kim, Sun Yeou
    Lee, Seok-Yong
    Jang, Choon-Gon
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2007, 87 (01) : 41 - 47
  • [38] 5-HT1B receptor in the suprachiasmatic nucleus of the common marmoset (Callithrix jacchus)
    Cavalcante, Jeferson S.
    de Pontes, Andre L. B.
    Engelberth, Rovena C. G. J.
    Cavalcante, Judney C.
    Nascimento, Expedito S., Jr.
    Borda, Janaina S.
    Pinato, Luciana
    Costa, Miriam S. M. O.
    de Toledo, Claudio A. B.
    NEUROSCIENCE LETTERS, 2011, 488 (01) : 6 - 10
  • [39] Effects of 5-HT1A Receptor Antagonist and 5-HT2A Receptor Agonist on Morphine Withdrawal
    Ramezani, Mahdi
    Shahidi, Siamak
    Afshar, Simin
    Habibi, Parisa
    Hashemi-Firouzi, Nasrin
    NEUROCHEMICAL JOURNAL, 2024, 18 (02) : 321 - 330
  • [40] Corticosterone responses in 5-HT1B receptor knockout mice to stress or 5-HT1A receptor activation are normal
    Bouwknecht, JA
    van der Gugten, J
    Hijzen, TH
    Maes, RAA
    Hen, R
    Olivier, B
    PSYCHOPHARMACOLOGY, 2001, 153 (04) : 484 - 490